Lurasidon Teva 37 mg filmom obložene tablete
Name | Lurasidon Teva 37 mg filmom obložene tablete |
---|---|
Marketing Authorisation Number | HR-H-884934101 |
Active Substance | lurasidonklorid |
Composition | jedna filmom obložena tableta sadrži lurasidonklorid što odgovara 37,2 mg lurasidona |
Pharmaceutical Form | Filmom obložena tableta |
Manufacturer | Teva Operations Poland Sp. z o.o., Krakow, Poljska Elpen Pharmaceutical Co.Inc. (SA), Pikermi, Attica, Grčka |
Marketing Authorisation Holder | Teva B.V., Swensweg 5, Haarlem, Nizozemska |
Marketing Authorisation Date | 13.06.2024 |
MA Period of Validity | 13.06.2029 |
Classification Number | UP/I-530-09/23-01/103 |
Registration Number | 381-12-01/171-24-06 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | N05AE05 |
SmPC | download |
PL | download |